Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- FJPWA Withholds Conclusion on Cooperation in Preliminary Drug Price Survey
November 4, 2002
- EU Presents Proposals for Regulatory Reform in Japan
November 4, 2002
- Price Settlement Rate 53.5% at the End of September: VITAL-NET
November 4, 2002
- REGULATORY NEWS IN BRIEF
November 4, 2002
- Bio Drugs to Account for 30% of All Drugs in 2010: Mr Nagayama at Medical Forum
November 4, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 4, 2002
- Kuraya Sanseido to Achieve 2% Operating Profit Rate by Further Cutting Costs
November 4, 2002
- Takeda Develops Simulation Software to Predict Prognosis of Diabetic Complications
November 4, 2002
- Yoshitomi to Further Specialize in Psychiatric Field
November 4, 2002
- Nihon Schering Introduces HTRF Technology for HTS
November 4, 2002
- IMS Japan to Communicate Closely with Wholesalers to Dispel Misunderstanding
November 4, 2002
- JCQHC to Start Publishing Therapeutic GLs from Next Year
November 4, 2002
- Drug Market to Expand to \5,965 Bil. in FY2002: Analyst
November 4, 2002
- PRESS SEMINAR
November 4, 2002
- Review Fees to Be Hiked in April 2004
October 28, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 28, 2002
- Council Recommends Strategic Approaches toward IP
October 28, 2002
- WORLD NEWS IN BRIEF
October 28, 2002
- 3 Active Ingredients Including Flunase Nasal Solution Approved
October 28, 2002
- Sankyo Acquires Cider Sante's Subsidiary of France
October 28, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…